Loading your page…
HIV Infections
Marketing Authorisation Holder: Gilead Sciences Ireland UC
EMA Authorisation: 21/04/2016
INN: emtricitabine;tenofovir alafenamide
AI Drug & Interaction Analysis
Free account required
Ask Osler about Descovy: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
